Maximus: Fiscal Q4 Earnings Snapshot

Maximus Inc. (MMS) reported fiscal Q4 profit of $97M, or $1.83 per share, beating estimates. Revenue was $1.3B, also exceeding forecasts. Full-year profit was $392.6M, with revenue at $5.23B. The company expects FY earnings of $7.50-$8 per share and revenue of $5.45B-$5.65B.

Original reporting
Published Nov 19, 2026, 11:43 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 19, 2026, 11:55 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Maximus: Fiscal Q4 Earnings Snapshot — source image
Decision brief

The 30-second read

$MMSBullishMed
01

Why it matters

Traders can update near-term EPS/revenue expectations based on the beat versus Zacks estimates and re-anchor valuation to the provided full-year ranges.

02

Market read

A company-specific earnings beat plus explicit full-year guidance typically drives estimate revisions and can move the stock if investors were positioned for a miss.

03

What to watch

The article does not break out segment performance, backlog, contract wins, or margin drivers, which are often what determine whether guidance is viewed as durable.

Relevance 8/10Novelty 7/10Timing: reported Thursday, use for same-day positioning and estimate updates

Background

Maximus is a government health services provider; this is a fiscal Q4 earnings snapshot with consensus comparisons and full-year guidance.

Company-level read

Ticker impact

$MMSBullishMedium confidence
Context

Maximus reported fiscal Q4 profit of $97 million and adjusted EPS $2.11, beating analysts’ $1.88 estimate, plus revenue $1.3B vs $1.29B.

Expected impact

Likely upward bias as the market digests the EPS beat and aligns expectations to the company’s stated full-year guidance range.

Evidence & confidence

The article provides a first-report earnings print with both EPS and revenue beats versus consensus, plus explicit full-year guidance ranges that can drive near-term estimate revisions.

Market effects

Reinforces demand visibility for government health services outsourcing, but no cross-company read-across is provided.

Limited, as the story is company-specific with no broader regional datapoints.

Low, since it is a US-listed single-issuer earnings/guidance update.

Counterpoint

The guidance ranges may still be the main driver, and the beat could be partially offset if investors focus on margin sustainability rather than headline EPS.

Key entities

  • Maximus Inc.

    Reported fiscal Q4 profit, adjusted EPS, revenue, and issued full-year earnings and revenue guidance.

  • Zacks Investment Research

    Provided the analyst consensus estimates referenced in the earnings comparison.

Related articles

$MMSMedAI 8/10

Maximus Misses Fourth-Quarter Earnings Estimates but Forecasts Fiscal 2027 Revenue Above Expectations

Maximus Inc. (MMS) reported Q4 earnings and revenue below estimates, with EPS at $2.11 vs. $2.31 expected and revenue at $1.30B vs. $1.32B. Despite this, fiscal 2027 revenue guidance of $5.45B-$5.65B exceeds expectations, while EPS guidance of $7.50-$8.00 falls short. The company completed its acquisition of Agile Defense, expected to contribute to fiscal 2027 revenue.

$MMSMedAI 8/10

Maximus misses Q4 estimates, guides fiscal 2027 above views

Maximus Inc. (MMS) reported Q4 adjusted EPS of $2.11, missing estimates by $0.20, with revenue at $1.3B, down 1.3% YoY. For fiscal 2027, MMS guided revenue to $5.45B-$5.65B, above consensus, but EPS guidance was below expectations. The company attributed revenue decline to lower disaster support and temporary program volumes. MMS completed the acquisition of Agile Defense, expecting it to contribute to fiscal 2027 revenue.

$MMSLow

MAXIMUS, INC. (MMS): Results of Operations and Financial Condition

MAXIMUS, INC. (MMS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Item 2.02 Results of Operations and Financial Condition. On November 19, 2026, the Company issued a press release announcing its financial results for the quarter and fiscal year ended September 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this report. Th

$MMSMed

Maximus Sees Growth In FY27 - Update

Maximus (MMS) reported Q4 results and initiated FY27 guidance, projecting adjusted earnings of $7.50-$8.00 per share on revenue of $5.45B-$5.65B, citing lower-end expectations. The outlook excludes a $1.05 per share benefit from FY26 and includes Agile Defense's contribution. MMS stock was up 0.57% in pre-market trading at $65.60.